Smith & Nephew SNATS SG&A Expenses 2010-2024 | SNN
Smith & Nephew SNATS annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Smith & Nephew SNATS sg&a expenses for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
- Smith & Nephew SNATS sg&a expenses for the twelve months ending December 31, 2024 were $0M, a 0% increase year-over-year.
- Smith & Nephew SNATS annual sg&a expenses for 2024 were $3.1B, a 1.47% increase from 2023.
- Smith & Nephew SNATS annual sg&a expenses for 2023 were $3.055B, a 6.08% increase from 2022.
- Smith & Nephew SNATS annual sg&a expenses for 2022 were $2.88B, a 5.88% increase from 2021.
| Smith & Nephew SNATS Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $3,100 |
| 2023 | $3,055 |
| 2022 | $2,880 |
| 2021 | $2,720 |
| 2020 | $2,562 |
| 2019 | $2,693 |
| 2018 | $2,497 |
| 2017 | $2,360 |
| 2016 | $2,366 |
| 2015 | $2,641 |
| 2014 | $2,471 |
| 2013 | $2,210 |
| 2012 | $2,050 |
| 2011 | $2,101 |
| 2010 | $1,860 |
| 2009 | $1,864 |
| Smith & Nephew SNATS Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2015-12-31 | |
| 2015-06-30 | |
| 2014-12-31 | $656 |
| 2014-09-30 | $634 |
| 2014-06-30 | $661 |
| 2014-03-31 | $520 |
| 2013-12-31 | $585 |
| 2013-09-30 | $528 |
| 2013-06-30 | $550 |
| 2013-03-31 | $547 |
| 2012-12-31 | $528 |
| 2012-09-30 | $481 |
| 2012-06-30 | $512 |
| 2012-03-31 | $529 |
| 2011-12-31 | $555 |
| 2011-09-30 | $517 |
| 2011-06-30 | $521 |
| 2011-03-31 | $508 |
| 2010-12-31 | $476 |
| 2010-09-30 | $452 |
| 2010-06-30 | $468 |
| 2010-03-31 | $464 |
| 2009-12-31 | $529 |
| 2009-09-30 | $443 |
| 2009-06-30 | $451 |
| 2009-03-31 | $441 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $12.359B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||